Novo Nordisk CEO And SVP On Ozempic And Wegovy
Following is the unofficial transcript of a CNBC interview with Novo Nordisk A/S (NYSE:NVO) CEO Lars Fruergaard Jørgensen, Novo Nordisk A/S Global Drug Discovery SVP Karin Conde-Knap
Source: valuewalk.com